We are live on
!
Find out more
SL
Summitry LLC Portfolio holdings
AUM
$3.04B
1-Year Est. Return
17.05%
This Fund
S&P 500
This Quarter
Est. Return
+1.66%
1 Year Est. Return
+17.05%
3 Year Est. Return
+68.13%
5 Year Est. Return
+77.78%
10 Year Est. Return
+281.24%
AUM
$877M
AUM Growth
+$21.6M
(+2.5%)
Cap. Flow
+$11.5M
Cap. Flow
% of AUM
1.31%
Top 10 Holdings %
Top 10 Hldgs %
45.75%
Holding
68
New
2
Increased
36
Reduced
15
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mondelez International
MDLZ
|
+$17.5M |
| 2 |
TWX
Time Warner Inc
TWX
|
+$11.6M |
| 3 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$1.08M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$683K |
| 5 |
Diageo
DEO
|
+$665K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$15.6M |
| 2 |
Microsoft
MSFT
|
+$5.54M |
| 3 |
HBI
Hanesbrands
HBI
|
+$916K |
| 4 |
FISV
Fiserv Inc
FISV
|
+$755K |
| 5 |
Wells Fargo
WFC
|
+$556K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 26.17% |
| 2 | Miscellaneous | 16.28% |
| 3 | Industrials | 16.07% |
| 4 | Technology | 14.13% |
| 5 | Consumer Discretionary | 8.6% |
Similar funds
JFGIW
GFA
SOAM
HCC
CA
CPC
BCM
CFM
Summitry LLC's Q2 2015 Portfolio in Review
As of Q2 2015, Summitry LLC held 68 positions worth $877M, up 2.5% from $855M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Summitry LLC's Q2 2015 filing shows 2 new, 36 increased, 15 reduced and 3 closed positions. Its largest new stake was Mondelez International: 447,575 shares worth $18.4M. The largest sale was Teva Pharmaceuticals, an estimated $15.6M.
By sector, the portfolio is most concentrated in Financials at 26% of assets, up from 25% a quarter earlier, followed by Miscellaneous and Industrials.
- Summitry LLC's largest Q2 2015 buy was Mondelez International: 447,575 shares worth $18.4M.
- Summitry LLC added most to iShares 1-5 Year Investment Grade Corporate Bond ETF in Q2 2015, an estimated $1.08M increase.
- Summitry LLC's biggest Q2 2015 reduction was Teva Pharmaceuticals, cutting an estimated $15.6M.
- Summitry LLC fully exited Hanesbrands in Q2 2015, selling an estimated $916K.
- Summitry LLC's ten largest holdings make up 46% of its $877M portfolio in Q2 2015.
- Summitry LLC opened 2 new positions and closed 3 in Q2 2015.
- Summitry LLC's portfolio value rose 2.5% quarter-over-quarter to $877M.
Based on Summitry LLC's 13F filing for Q2 2015, filed 6 Aug 2015.